#USA #Scottsdale #Innovative Health #electrophysiology #Reprocessing Performance

New Industry Benchmark for Electrophysiology Reprocessing

Innovative Health, a frontrunner in medical device reprocessing, recently unveiled the first edition of its
the Reprocessing Performance Benchmark. This groundbreaking announcement aims to assist electrophysiology programs in the healthcare sector to measure and enhance their device reprocessing initiatives. Through an extensive analysis drawn from device utilization and purchase records from multiple U.S. electrophysiology programs, the report provides valuable insights into the state of reprocessing activities across the industry.

Unveiling the Data

According to the findings, the average electrophysiology program saw a remarkable 28% increase in the utilization of reprocessed devices over the last year. This growth stemmed from two main factors: a notable 18% rise in the number of diverse products used, combined with a deeper commitment to utilizing products that had already been adopted. This dual approach indicates that successful programs are not only expanding their product offerings but are also maximizing the use of existing reprocessed devices.

In stark contrast, the data reveals a significant performance gap between average programs and the top performers. While the typical participating program reported usage of around 213 reprocessed devices, the elite 90th-percentile programs actively utilized 2,049 devices across 27 distinct product families. This difference underscores the substantial potential for growth and development within the field of electrophysiology.

Insights and Implications

Rick Ferreira, the CEO of Innovative Health, emphasized the importance of the benchmarking report, stating, "Hospitals often recognize when their reprocessing volumes are increasing. However, until this benchmark, they lacked a clear standard to evaluate whether their programs were maximizing existing opportunities. This allows leaders in the field of electrophysiology to better understand their growth trajectory, identify practices from successful programs, and pinpoint areas for future improvement."

The report provides a series of key takeaways:

• - Expected Growth: The average electrophysiology program should aim for growth, evidenced by the 28% increase in reprocessed device utilization.
• - Different Scales of Operation: High-performing programs operate on a drastically different scale compared to average programs, showcasing the need for hospitals to reassess their own operational standards.
• - Concentration of Utilization: Notably, ten product families account for approximately 65% of all reprocessed products. Therefore, for ongoing growth, it's critical for programs to extend their reach beyond these established product families.
• - Under-Adopted Categories: Certain categories, including mapping catheters and transseptal needles, have seen adoption rates of just 49% and 33%, respectively, compared to the overwhelming 95% for diagnostic catheters.
• - Diverse Adoption Rates for New Technologies: The report also highlights discrepancies in the adoption rates for new technologies. For instance, usage of cutting-edge pulsed field ablation devices surged by a staggering 1,230% within just a year, compared to a more modest 135% for radiofrequency devices. Meanwhile, over 85% of catalog items analyzed maintained a consistent volume over seven years, indicating that established products continue to hold clinical relevance.

The findings paint a picture of an electrophysiology market characterized by dynamic change: while emerging technologies can rapidly reshape utilization metrics, long-recognized products continue to play a significant role in clinical practices.

Strategic Implications

Ferreira adds that constructing a reprocessing strategy requires more than simply following last year’s purchasing activities or focusing on the latest device trends. Hospitals are urged to develop an adaptable operating framework that not only broadens their reprocessing initiatives but also continuously reevaluates the performance of existing product portfolios. This guidelines provided in the report can serve as a practical tool for hospitals to align their operations with the best practices of industry leaders.

The Reprocessing Performance Benchmark report contains nine actionable insights that hospitals can compare against their own data. Interested parties can access the full report on Innovative Health's website.

Innovative Health aims to be at the forefront of advancing medical device reprocessing by facilitating smarter utilization of devices in cardiology and electrophysiology programs across the healthcare landscape.

Conclusion

This innovative benchmarking initiative not only underscores the growth trajectory of electrophysiology programs but also highlights the vast opportunities available for hospitals aiming to optimize their reprocessing strategies. By leveraging these insights, healthcare facilities can ensure they are not just participants, but key players in the evolution of efficient and effective patient care practices.